ADD ANI AS A TRUSTED SOURCE
googleads
ANI Logo
Menu
Business

Sun Pharma signs licensing pact with CSIR-IICT

Mumbai (Maharashtra) [India], Aug 14 (ANI): Sun Pharmaceutical Industries said on Wednesday that it has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology (CSIR-IICT) in Hyderabad for patents related to certain compounds.

ANI Aug 14, 2019 14:25 IST googleads

Sun Pharma has 42 manufacturing facilities across six continents

Mumbai (Maharashtra) [India], Aug 14 (ANI): Sun Pharmaceutical Industries said on Wednesday that it has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology (CSIR-IICT) in Hyderabad for patents related to certain compounds.
These compounds have potential therapeutic activity across multiple indications in the pharma major's specialty focus areas. Under the terms of the licence agreement, Sun Pharma gets an exclusive global licence for the patents and any other future patents covered in the agreement.
Sun Pharma will pay CSIR-IICT upfront and potential development, regulatory and sales milestone payments totalling up to Rs 240 crore plus royalties on net sales from commercialisation of the products developed using these patents. The pharma company will be responsible for development, regulatory filings, manufacturing and commercialisation of these potential products.
"This collaboration with CSIR-IICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline," said Managing Director Dilip Shanghvi.
"CSIR-IICT is well-known for its high-quality research and we are proud to be associated with them. We are making earnest efforts to bring innovations from Indian research institutes to the market to address the unmet needs of patients globally. Our collaboration with CSIR-IICT is a step in this direction," he said in a statement.
This agreement will facilitate addition of pre-clinical candidates to Sun Pharma's global specialty pipeline. A successful clinical development of these potential compounds may enable Sun Pharma to commercialise pharmaceutical products for various therapeutic indications over the long term.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. It has 42 manufacturing facilities across six continents. (ANI)

Get the App

What to Read Next

Business

Fractal unveils intelligent sales agents to accelerate B2B growth

Fractal unveils intelligent sales agents to accelerate B2B growth

Mumbai (Maharashtra) [India], March 11: Fractal (www.fractal.ai), a publicly listed global enterprise AI company serving Fortune 500® organizations, launched new intelligent agents within Flyfish.ai (www.flyfish.ai), its AI-native revenue acceleration platform built to reimagine how modern revenue teams operate, compete, and win. The upgraded platform brings together more than 35 coordinated AI agents that work across the entire sales lifecycle, from researching accounts and identifying buying signals to drafting personalized outreach and maintaining accurate pipelines in real time.

Read More
Business

RDash and NICMAR University, Hyderabad launch industry-integrated

RDash and NICMAR University, Hyderabad launch industry-integrated

Hyderabad (Telangana) [India], March 9: NICMAR University of Construction Studies (NUCS), Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with RDash, an AI-powered construction management software, to equip students with industry-ready digital project management capabilities and real-world construction execution skills.

Read More
Business

LOTTE Biologics to Participate in DCAT Week 2026 in New York

LOTTE Biologics to Participate in DCAT Week 2026 in New York

Seoul [South Korea], March 9: LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global presence in the contract development and manufacturing organization (CDMO) sector.

Read More
Business

Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025

Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025

Mumbai (Maharashtra) [India], March 6: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its recognition among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA). Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally, and the leader across all sectors in India, surpassing both Indian and international peers.

Read More
Business

InSolare Energy Partners with CSIR-SERC to Strengthen Structural

InSolare Energy Partners with CSIR-SERC to Strengthen Structural

Mumbai (Maharashtra) [India], March 6: InSolare Energy Limited has signed a Memorandum of Understanding (MoU) with CSIR-Structural Engineering Research Centre (CSIR-SERC), a premier national laboratory under the Council of Scientific and Industrial Research (CSIR), known for its expertise in structural analysis, design, and testing, has developed indigenous technologies and built advanced facilities to support industry with high-precision engineering evaluation.

Read More
Business

Billroth Hospital Launches Advanced Cardiac & Pulmonary Specialty

Billroth Hospital Launches Advanced Cardiac & Pulmonary Specialty

Chennai (Tamil Nadu) [India], March 2: Billroth Hospitals, one of the city's leading multispecialty centres and a pioneer in advanced laparoscopic and laser procedures, marked a significant milestone with the launch announcement of its comprehensive Cardiac & Pulmonary Specialty Services, with a new Heart Dysfunction Clinic and Pulmonary Embolism Referral Center recently at Hotel The Leela Palace, Chennai.

Read More
Business

Getac Brings AI-Powered Rugged Computing Portfolio to India

Getac Brings AI-Powered Rugged Computing Portfolio to India

New Delhi [India], February 27: Getac Technology Corporation (Getac), a leading provider of rugged computing and mobile video solutions and a manufacturer with advanced in-house capabilities, today announced the launch of its AI-ready rugged device portfolio in India. Built for India's diverse and demanding operating environment, from extreme weather to remote, infrastructure-challenged locations, the new lineup combines cutting-edge AI capabilities with proven rugged reliability for field professionals working across the country's pharmaceutical, manufacturing, automotive, and transportation sectors.

Read More
Business

Avery Pharmaceuticals Show Innovative Nutraceutical Products

Avery Pharmaceuticals Show Innovative Nutraceutical Products

Mumbai (Maharashtra) [India], February 27: Avery Pharmaceuticals Pvt. Ltd. showcased its innovative Mouth Dissolving Strips and CDMO solutions at Vitafoods India 2026, held from February 11-13 at the Jio World Convention Centre in Mumbai. Over 500 visitors engaged with our booth, showcasing the robust interest from key players across the pharmaceutical, nutraceutical, and healthcare sectors. . The participation enabled the company to demonstrate its scientific capabilities, initiate new business conversations, and strengthen relationships with existing and prospective partners.

Read More
Business

SteinCares and Shilpa Biologicals Strike into Licensing Agreement

SteinCares and Shilpa Biologicals Strike into Licensing Agreement

San Jose [Costa Rica]/ Raichur (Karnataka) [India], February 25: SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd. (SBPL), a fully integrated biopharmaceutical subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), announce a strategic licensing agreement to commercialize a biosimilar across Latin America. New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform. Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares' leadership in biosimilars across Latin America. Agreement marks the first product from this strategic partnership and Shilpa Biologicals' entry into the Latin American market.

Read More
Business

UN Road Safety Envoy Jean Todt Slams Fake Helmets, Calls

UN Road Safety Envoy Jean Todt Slams Fake Helmets, Calls

New Delhi [India], February 24: In a significant step towards strengthening India's road safety ecosystem, Steelbird Helmets, in collaboration with TRAX - Road Safety NGO and Central Road Research Institute (CSIR-CRRI), hosted "Mission: Save Lives On Roads, India -- An Integrated Road Safety Meet" at The Leela Palace, Delhi.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.